Close
Listen

Aims

  • Search for quantitative biomarkers with advanced MRI methods for improved diagnosis, staging, and assessment of aggressiveness of localized prostate cancer (extrapolation to other cancers)
  • Development and evaluation of advanced MRI techniques for advanced (oligometastatic and castrate-resistant) prostate cancer
  • Development and validation of nanoparticle-enhanced MRI in prostate, rectal, H&N, and upper abdominal cancers.
  • Implementation of 3D motion-incorporating MRI in the abdomen (quantitative T2*, water/fat, T1)


go to main content
Research Research groups Biomedical magnetic resonance

About Biomedical magnetic resonance

We develop, implement, and test new MR imaging and spectroscopy technology at clinical and ultra-high magnetic field MR scanners to improve fundamental understanding, diagnosis, and treatment response in cancer.

Research group leader

prof. dr. ir. Tom Scheenen

contact form

Aims

See our most important goals.

read more

Publications

See some of our most important scientific articles.

read more
Close
Listen

Publications

See the publication list of the research group leader on Web of Science.


Profile page

See the group leader's profile.

see page

Research programs

Programs that are connected to this research group.